SEC Form 4 · accession 0001179110-17-011479
Theravance Biopharma, Inc. · TBPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George M Whitesides
Director
Period of report
Aug 11, 2017
Accepted (ET)
Aug 14, 2017 · 8:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001583107
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Aug 11, 2017 | P | 4,000 | $24.691 | A | 4,000 | I | By Trust |
| Ordinary Shares | holding | — | — | — | 184,392 | D | ||
| Ordinary Shares | holding | — | — | — | 48,662 | I | By Family Trust |
Table II — derivative securities
No Table II lines on this filing.